Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 30, 2019
Sameer Narayan, market expert, speaks on pharma stocks. He says, 'The sector has seen a lot of upheaval because the whole story started earlier with the the US generic market. That story has pretty much played out in the early part of 2000s and then as it started maturing, the market became very competitive. India had the largest FDA approved plants outside the US. The competition just ensured that the US regulator woke up and said that suddenly we seem to be getting a lot of goods from this country and so let us go and do a more detailed check.' Listen in for more details!